It’s understandable that the government was unprepared for the crisis and vaccine supplies are low nationwide. It’s up to Pfizer-BioNTech, Moderna and the federal government to increase supply to meet the demands. However, the state should re-evaluate its distribution plan so it is more equitable for all.